IP Verse

Mesalazine Tablet Having Improved Dissolution - EP2611429

The patent EP2611429 was granted to Disphar on Feb 21, 2018. The application was originally filed on Sep 1, 2011 under application number EP11752210A. The patent is currently recorded with a legal status of "Revoked".

EP2611429

DISPHAR
Application Number
EP11752210A
Filing Date
Sep 1, 2011
Status
Revoked
Jul 10, 2020
Grant Date
Feb 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TILLOTTS PHARMANov 21, 2018BECK GREENER -

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP2072043
DESCRIPTIONWO2009090484
DESCRIPTIONWO9832676
INTERNATIONAL-SEARCH-REPORTEP2072043
INTERNATIONAL-SEARCH-REPORTUS2009036414
INTERNATIONAL-SEARCH-REPORTWO2009047802
INTERNATIONAL-SEARCH-REPORTWO9826767
OPPOSITIONEP2072043
OPPOSITIONJP2008074790
OPPOSITIONUS2002068088
OPPOSITIONUS2009036414
OPPOSITIONUS4539198
OPPOSITIONUS5108758
OPPOSITIONWO2006102446
OPPOSITIONWO2009047802
OPPOSITIONWO9826767

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BRUNNER ET AL., ALIMENT PHARMACOL THER, vol. 23, pages 137 - 144-
DESCRIPTION- J. N. C. HEALEY, "Gastrointestinal Transit and Release of Mesalazine Tablets in Patients with Inflammatory Bowel Disease", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, (1990), vol. 25, no. S172, pages 47 - 51-
DESCRIPTION- L. LACHMAN, H.A LIEBERMAN, J.L KANIG, The theory and practice of industrial pharmacy, LEA & FEBIGER, (1976), pages 112 - 116-
DESCRIPTION- M.E. AULTON, Pharmaceutics, The science of dosage form design, (2002), pages 411 - 412-
DESCRIPTION- US Pharmacopoeia, pages 22 53 - 2254-
OPPOSITION- "Drug Surface Calculations and Determinations", Eudragit® Application Guidelines, (20090000), page 1, XP055534722-
OPPOSITION- Kibbe H., "Polymethacryates", Handbook of Pharmaceutical Excipients, (20000000), pages 401 - 406, XP055534692-
OPPOSITION- Kibbe, "Hydroxypropyl methyl cellulose", Handbook of Pharmaceutical Excipients, (20000000), pages 252 - 255, XP055534664-
OPPOSITION- "Remington The Science and Practice of Pharmacy", Remington The Science and Practice of Pharmacy, (20130000), page 338 and 967, XP055534716-
OPPOSITION- "Summary of Product Characteristics (SmPC) for Asacol® 800 mg MR tablets", medicines.org, (20160400), pages 1 - 6, XP055534708-
OPPOSITION- "Summary of Product Characteristics (SmPC) for Salofalk® 500 mg gastro-resistant tablets", medicines.org, (20180100), pages 1 - 5, XP055534701-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents